Join us for our June Study Day and let national and international experts bring you up to date on the de-escalation of prescription opioids.
The programme includes talks about best practices in Opioid prescribing, the neurobiology of substance abuse and addiction and many other relevant topics.
Organisers: Dr Dev Srivastava, Dr Sumit Gulati and Dr Adam Samways
Please note that this is an in-person event only.
|09:20||Welcome (Dr Dev Srivastava)|
Public health impact and contribution of prescription opioids
Speaker: Prof Roger Knaggs
Neurobiology of substance abuse and addiction
Speaker: Dr Katherine Herlinger
Best practices in Opioid prescribing
Speaker: Dr Sunil Dasari
Factors that increase vulnerability to opioid tolerance, hyperalgesia and overdose
Speaker: Prof Timothy Hales
RCT evidence in opioid de-escalation: the I-WOTCH Trial
Speaker: Prof Sam Eldabe
How to perform prescription opioid tapering in secondary care: Issues with complex patients including unintended consequences
Speaker: Prof (Dr) Sailesh Mishra & Helen Franklin
Opioid de-escalation service - A nurse’s view
Speaker: Helen Burke
|16:10||DISCUSSION, FEEDBACK & CLOSURE|
Programme subject to change.
|Senior Fellows||Student/ Foundation year||Non Members|
ESTEVE is an international pharmaceutical innovator and partner with a rich heritage and a purposeful global expansion approach. Medications we supply today help millions of patients worldwide.
ESTEVE has an ambitious vision to become an international proprietary pharma leader in specialty therapeutics. We have a broad and innovative product portfolio in the fields of oncology, COPD and cardiovascular system, neurology, analgesia and ophthalmology.